Printer Friendly

Articles from Journal of Commercial Biotechnology (April 1, 2008)

1-22 out of 22 article(s)
Title Author Type Words
A new approach to improve technology commercialisation in university medical schools. Price, Courtney; Huston, Richard; Meyers, Arlen D. Report 3102
Biotechnology business models work: evidence from the pharmaceutical marketplace. Glick, J. Leslie Report 6794
EC: Regulation on Advanced Therapy Medicinal products to enter into force. 500
Editorial. Friedman, Yali 499
EU: Enlarged Board of Appeal decides on the requirements for divisional applications. 918
EU: EPC 2000 introduces changes to the patentability of second and subsequent medical use of known compounds. 404
Export compliance for life sciences. Avellanet, John Report 1188
Maryland and Virginia unite at 2007 Mid-Atlantic Bio Conference. King, Harley 1255
New ECJ reference in relation to Supplementary Protection Certificates for Medicinal Products. 541
Risk management for the biotechnology industry: a Canadian perspective. Vanderbyl, Sandra; Kobelak, Sherry Report 6779
Singapore's biomedical sciences landscape. Yeoh, Keat-Chuan Report 2675
Social responsibility for the use of genes, genomes and biotechnology in biotechnology companies: a commentary from the bioethical viewpoint. Okada, Yoshihiro; Watanabe, Kazuo N. Report 9552
Special update: the FDA Amendments Act 2007. 5158
Stem Cell Wars: Inside Stories from the Frontlines. Skrepnek, Grant H. Book review 2044
Sweden: The Swedish system of generic substitution, interchangeability between reference drugs and generics. 385
The Netherlands: Alternext Amsterdam--An attractive alternative?. 372
The Netherlands: Implications of the new Medicines Act in the Netherlands. 423
The Netherlands: Inclusion in the G-Standard of a generic medicine held not to be infringing. 549
The Netherlands: New developments in Dutch patent litigation: Evidential seizure The pharmaceutical company Teva. 455
UK: Declaratory jurisdiction of the English Courts as to certain aspects of the validity of divisional patent applications that are still pending at the EPO. 468
UK: the OFT's report into medicines distribution in the UK. 451
Valuing biotechnology companies: does classification by technology type help? Loh, Jacqueline; Brooks, Robert Report 4653

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |